NCT07510191

TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response

RecruitingPHASE4INTERVENTIONAL

Trial Details

Start: 2026-03-01Est. Completion: 2028-12-31

Enrollment target: 312 participants

Locations

The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China

Contact

Wei Wang, MDwangw239@mail.sysu.edu.cn 86-18702046420

Other microbiome trials you might be interested in

A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier HomeostasisRecruiting

Inflammatory Bowel Disease

Crohn's Disease (CD) and Ulcerative Colitis (UC), collectively known as inflammatory bowel disease (IBD), are two of the…

Chicago, United StatesEst. completion Sep 1, 2026

View Trial →

VIBRANT-IBD: Brain Effects of Non-Invasive Vagus Nerve Stimulation in IBD RemissionEARLY_PHASE1ENROLLING_BY_INVITATION

Inflammatory Bowel Diseases (IBD)Remission of IBDIn AdultsInflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)Crohn's Disease (CD)Ulcerative Colitis (UC)

The VIBRANT-IBD study is a pilot, prospective, single-arm feasibility study investigating the effects of non-invasive va…

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.